Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 3:2
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (50.0%)Phase 4
2 (50.0%)A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 447
- Registration Number
- NCT00257010
A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents
Phase 3
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 866
- Registration Number
- NCT00210483
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
Phase 4
Completed
- Conditions
- MigraineClassic MigraineCommon Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 406
- Registration Number
- NCT00210496
A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache
Phase 4
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 378
- Registration Number
- NCT00210509
News
No news found